| Literature DB >> 24424170 |
Osnat Jarchowsky Dolberg1, Yair Levy2.
Abstract
Aplastic anemia (AA) is a disease characterized by pancytopenia and hypoplastic bone marrow caused by the decrease of hematopoietic stem cells. The pathogenesis of AA is complex and involves an abnormal hematopoietic microenvironment, hematopoietic stem cell/progenitor cell deficiencies and immunity disorders. Survival in severe aplastic anemia (SAA) has markedly improved in the past 4 decades because of advances in hematopoietic stem cell transplantation, immunosuppressive and biologic drugs, and supportive care. Herein, we will update the main issues concern AA according to our literature review.Entities:
Keywords: Aplastic anemia; Autoimmunity; Immunosuppressive therapy; Pancytopenia
Mesh:
Substances:
Year: 2014 PMID: 24424170 DOI: 10.1016/j.autrev.2014.01.014
Source DB: PubMed Journal: Autoimmun Rev ISSN: 1568-9972 Impact factor: 9.754